Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side
effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically …

The relationship between gut microbiota and neurological diseases, including chronic pain,
has received increasing attention. The gut microbiome is a crucial modulator of visceral …

There are now close to 17 million cancer survivors in the United States, and this number is
expected to continue to grow. One decade ago the Institute of Medicine report, From Cancer …

Worldwide, the prevalence of cancer is rising and so too is the number of patients who
survive their cancer for many years thanks to the therapeutic successes of modern oncology …

Chemotherapy-induced peripheral neuropathy (CIPN) is a major challenge, with increasing
impact as oncological treatments, using potentially neurotoxic chemotherapy, improve …

CRC is the third most commonly diagnosed malignancy and the fourth leading cause of
cancer-related death in the world. With advances in treatment, colorectal cancer is being …

Azole antifungals are first-line options in the prophylaxis and treatment of invasive fungal
infections. They are often used for prolonged (weeks to months) periods of time, particularly …

Platinum‐induced peripheral neurotoxicity (PIPN) is a common side effect of platinum‐
based chemotherapy that may cause dose reduction and discontinuation, with oxaliplatin …

Geriatric syndromes are multifactorial conditions that are prevalent in older adults. Geriatric
syndromes are believed to develop when an individual experiences accumulated …

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a progressive,
enduring, and often irreversible adverse effect of many antineoplastic agents, among which …